Cancer Patients Europe Annual Activity Report 2022
CPE’s 2022 Annual Report: Organisation founded in March, 18 members across 13 countries, myC initiative launched, three EU projects funded, key partnerships established. Read More
Home »
2023
Joint Response to Call for Evidence on a Comprehensive Approach to Mental Health: Incontinence and Mental Health
EAU, WFIPP, ICS, and CPE call on the European Commission to include incontinence as a co-morbidity in the EU Mental Health Strategy and fund research. Read More
Better Decision-Making for Better Outcomes: A Call to Action on Harnessing the Power of Real-World Evidence
CPE, MEPs, and researchers call on EU policymakers to harness Real-World Evidence to improve health outcomes, regulatory decisions, and access to medicines.
Read More
The European Health Technology Assessment Regulation: The Political Will – Webinar Report
PCE and CPE’s February 2023 webinar report examines opportunities and challenges of the EU HTA Regulation with EC, MEPs, ESMO, EFPIA, and patient advocates. Read More
Enabling Effective Secondary Use of Health Data in Europe: Specific Recommendations for a Potential Opt-Out Mechanism for the EHDS
European health organisations including CPE issue recommendations on EHDS opt-out mechanism to protect research while ensuring data representativeness and equity. Read More
ThermoBreast Project Patient Survey on Breast Cancer Screening Experiences
ThermoBreast EU project survey invites women to share breast screening experiences to inform development of non-invasive, radiation-free detection technology. Read More
Patient Leadership to Tackle Cancer in Europe – Cancer Patients Europe’s Launch Event
CPE’s July 2023 Brussels launch event brought together MEPs, OECD, and stakeholders to discuss Europe’s Beating Cancer Plan, HTA, and patient leadership. Read More
Transforming EU Continence Health: A Manifesto for Policy Reform
This Manifesto, led by the European Association of Urology and co-signed by Cancer Patients Europe and other stakeholders, addresses the continence health challenge affecting… Read More
Awareness of Genomic Testing Among Patients with Breast Cancer in Europe – ESMO 2023 Poster
CPE’s ESMO 2023 poster reveals only 1 in 5 eligible breast cancer patients were told about genomic testing. See the European survey data. Read More
Awareness of Genomic Testing in Breast Cancer: A Call to Action Across Europe
CPE’s myC White Paper reveals 78% of eligible breast cancer patients were never told about genomic testing. Read the Call to Action for Europe. Read More